Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ASTH
    4. >
  4. Valuation

Valuation

-
stocks logo
ASTH
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is ASTH Overvalued？

ASTH is now in the zone, suggesting that ASTH current forward PE ratio of 28.51 is considered compare with the five-year average of 36.86.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

ASTH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ASTH.O
Astrana Health Inc
28.51
Average P/E: 19.72
1.95B
stocks logo
NRC.O
National Research Corp
12.81
Average P/E: 19.72
-22.16%
334.71M
stocks logo
QIPT.O
Quipt Home Medical Corp
loss
Average P/E: 19.72
115.05M
stocks logo
DGX.N
Quest Diagnostics Inc
17.86
Average P/E: 19.72
11.62%
19.04B

ASTH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

ASTH FAQs

Is ASTH currently overvalued based on its P/E ratio?

According to the provided data, ASTH's 5-year historical average forward P/E ratio is 36.86. ASTH forward P/E ratio is 28.51, which is categorized as Fair.

How has ASTH's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 44.35 to 35.03, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for ASTH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for ASTH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

ASTH PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
36.86
Current PE
28.51
Overvalued PE
56.25
Undervalued PE
17.46

ASTH EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
11.89
Current EV
8.79
Overvalued EV
18.01
Undervalued EV
5.76

ASTH P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
1.41
Current PS
0.68
Overvalued PS
2.41
Undervalued PS
0.41

ASTH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ASTH.O
Astrana Health Inc
28.51
Average P/E: 19.72
1.95B
stocks logo
NRC.O
National Research Corp
12.81
Average P/E: 19.72
-22.16%
334.71M
stocks logo
QIPT.O
Quipt Home Medical Corp
loss
Average P/E: 19.72
115.05M
stocks logo
DGX.N
Quest Diagnostics Inc
17.86
Average P/E: 19.72
11.62%
19.04B

ASTH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ASTH undervalued？Is ASTH overvalued compared to its competitors？

ASTH FAQs

Is ASTH currently overvalued based on its P/E ratio?

According to the provided data, ASTH's 5-year historical average forward P/E ratio is 36.86. ASTH forward P/E ratio is 28.51, which is categorized as Fair.

How has ASTH's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 44.35 to 35.03, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for ASTH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

What are the key indicators to watch for ASTH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ASTH undervalued？Is ASTH overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free